Denis MG - Search Results

1

Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer.

Heitzer E, van den Broek D, Denis MG, Hofman P, Hubank M, Mouliere F, Paz-Ares L, Schuuring E, Sültmann H, Vainer G, Verstraaten E, de Visser L, Cortinovis D. Heitzer E, et al. Among authors: denis mg. ESMO Open. 2022 Apr;7(2):100399. doi: 10.1016/j.esmoop.2022.100399. Epub 2022 Feb 21. ESMO Open. 2022. PMID: 35202954 Free PMC article. Review.

2

Predictive molecular pathology in non-small cell lung cancer in France: The past, the present and the perspectives.

Hofman P, Rouleau E, Sabourin JC, Denis M, Deleuze JF, Barlesi F, Laurent-Puig P. Hofman P, et al. Cancer Cytopathol. 2020 Sep;128(9):601-610. doi: 10.1002/cncy.22318. Cancer Cytopathol. 2020. PMID: 32885912 Free article. Review.

3

Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives.

Herbreteau G, Vallée A, Charpentier S, Normanno N, Hofman P, Denis MG. Herbreteau G, et al. Among authors: denis mg. J Thorac Dis. 2019 Jan;11(Suppl 1):S113-S126. doi: 10.21037/jtd.2018.12.18. J Thorac Dis. 2019. PMID: 30775034 Free PMC article. Review.

4

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

Fairley JA, Cheetham MH, Patton SJ, Rouleau E, Denis M, Dequeker EMC, Schuuring E, van Casteren K, Fenizia F, Normanno N, Deans ZC. Fairley JA, et al. BMC Cancer. 2022 Jul 12;22(1):759. doi: 10.1186/s12885-022-09849-x. BMC Cancer. 2022. PMID: 35820813 Free PMC article.

5

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).

Heeke S, Benzaquen J, Hofman V, Ilié M, Allegra M, Long-Mira E, Lassalle S, Tanga V, Salacroup C, Bonnetaud C, Fayada J, Gazoppi L, Ribeyre L, Castelnau O, Garnier G, Cattet F, Nanni I, de Fraipont F, Cohen C, Berthet JP, Leroy S, Poudenx M, Marquette CH, Denis MG, Barlesi F, Hofman P. Heeke S, et al. Among authors: denis mg. Clin Lung Cancer. 2020 Jan;21(1):56-65.e8. doi: 10.1016/j.cllc.2019.07.010. Epub 2019 Aug 3. Clin Lung Cancer. 2020. PMID: 31519454

6

Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project.

Beau-Faller M, Pencreach E, Leduc C, Blons H, Merlio JP, Bringuier PP, de Fraipont F, Escande F, Lemoine A, Ouafik L, Denis M, Hofman P, Lacave R, Melaabi S, Langlais A, Missy P, Morin F, Moro-Sibilot D, Barlesi F, Cadranel J; French Cooperative Thoracic Intergroup (IFCT). Beau-Faller M, et al. Lung Cancer. 2020 Feb;140:19-26. doi: 10.1016/j.lungcan.2019.10.013. Epub 2019 Nov 15. Lung Cancer. 2020. PMID: 31841714

7

EGFR T790M resistance mutation in non small-cell lung carcinoma.

Denis MG, Vallée A, Théoleyre S. Denis MG, et al. Clin Chim Acta. 2015 Apr 15;444:81-5. doi: 10.1016/j.cca.2015.01.039. Epub 2015 Feb 7. Clin Chim Acta. 2015. PMID: 25668228 Review.

8

Detection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samples.

Vallee A, Sagan C, Le Loupp AG, Bach K, Dejoie T, Denis MG. Vallee A, et al. Among authors: denis mg. Int J Oncol. 2013 Oct;43(4):1045-51. doi: 10.3892/ijo.2013.2056. Epub 2013 Aug 7. Int J Oncol. 2013. PMID: 23934203 Free PMC article.

9

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.

Vallée A, Marcq M, Bizieux A, Kouri CE, Lacroix H, Bennouna J, Douillard JY, Denis MG. Vallée A, et al. Among authors: denis mg. Lung Cancer. 2013 Nov;82(2):373-4. doi: 10.1016/j.lungcan.2013.08.014. Epub 2013 Aug 19. Lung Cancer. 2013. PMID: 24007628 No abstract available.

10

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients.

Herbreteau G, Vallée A, Knol AC, Théoleyre S, Quéreux G, Frénard C, Varey E, Hofman P, Khammari A, Dréno B, Denis MG. Herbreteau G, et al. Among authors: denis mg. Cancers (Basel). 2020 Jul 11;12(7):1871. doi: 10.3390/cancers12071871. Cancers (Basel). 2020. PMID: 32664549 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page